38 studies found for:    " January 26, 2011":" February 25, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Chemotherapy for Lung Cancer in HIV-positive Patients
Conditions: Non-small Cell Lung Cancer;   Hiv-positive
Intervention: Drug: Chemotherapy
22 Completed
Has Results
Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
Condition: HIV-1 Infection
Intervention: Drug: FTC/RPV/TDF
23 Active, not recruiting Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle
Condition: HIV
Interventions: Behavioral: FAmily CEntered (FACE) ACP;   Behavioral: Healthy Living Control
24 Completed
Has Results
Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination
Conditions: HIV;   Rabies
Intervention: Biological: rabies vaccines on day 0 and 3
25 Completed Vitamin D Supplements for HIV-positive Patients on cART
Condition: HIV-associated Co-morbidities
Interventions: Dietary Supplement: conventional vitamin D treatment;   Drug: tiered/titrated vitamin D dosing
26 Completed Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)
Condition: HIV-infected Children
Intervention: Drug: kaletra
27 Completed Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals
Condition: HIV-1 Infection
Intervention: Drug: Disulfiram
28 Completed Lung HIV Disease in a Large Cohort-Pitt
Conditions: Pulmonary Disease;   HIV;   Emphysema
Intervention:
29 Completed
Has Results
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
Condition: HIV-1 Infection
Intervention: Drug: depo-medroxyprogesterone acetate
30 Completed Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis
Conditions: Human Immunodeficiency Virus;   Hepatitis C
Intervention: Drug: Raltegravir 400 mg/12hours
31 Not yet recruiting Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)
Conditions: HPV Infection;   HIV Infection;   Syphilis
Intervention:
32 Completed Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers
Conditions: Neisseria Gonorrhoeae Infection;   Chlamydia Trachomatis;   HIV
Interventions: Drug: Monthly antibiotic;   Drug: Monthly placebo
33 Completed
Has Results
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab
34 Completed Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
Conditions: HIV Infection;   Hepatitis C Infection;   Fibrosis;   Inflammation
Intervention:
35 Completed HIV Prevention in Very High Risk Men Who Have Sex With Men
Condition: Risk Reduction Behavior
Intervention: Behavioral: Cognitive-behavioral therapy
36 Completed TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions
Condition: Healthy
Interventions: Drug: Darunavir (DRV);   Drug: ritonavir
37 Completed Abstinence-Linked Money Management Multisite
Conditions: Dual Diagnosis;   Cocaine Abuse;   Cocaine Dependence;   Polysubstance Abuse
Interventions: Behavioral: ATM;   Behavioral: Individual Drug Counseling
38 Completed Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects
Condition: Healthy
Interventions: Drug: Maraviroc;   Drug: Fosamprenavir/ritonavir;   Drug: Maraviroc + Fosamprenavir/ritonavir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page   
Study has passed its completion date and status has not been verified in more than two years.